Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Thermo Fisher Scientific (TMO) Stock: Fresh Deals, Wall Street Upgrades and Long‑Term Outlook as of December 4, 2025

Thermo Fisher Scientific (TMO) Stock: Fresh Deals, Wall Street Upgrades and Long‑Term Outlook as of December 4, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) is ending 2025 with strong momentum. The life‑science giant’s shares are trading around $570–$575 today, after a powerful rebound from mid‑year lows and a series of bullish analyst upgrades, strategic acquisitions and new partnerships. FinanceCharts This overview pulls together the latest news, forecasts and analyses up to December 4, 2025, to help investors understand…
D-Wave Quantum (QBTS) Stock Surges on Government Push and Analyst Upgrades: Full 2025 Outlook and 2026 Forecast

D-Wave Quantum (QBTS) Stock Surges on Government Push and Analyst Upgrades: Full 2025 Outlook and 2026 Forecast

As of the afternoon on December 4, 2025, D‑Wave Quantum Inc. (NYSE: QBTS) is trading around $28.37, up roughly 13% on the day, after hitting an intraday high of about $28.52 on heavy volume of more than 31 million shares. Over the last year, the stock has swung between $2.88 and $46.75, underscoring just how volatile this quantum computing pure‑play…
McDonald’s (MCD) Stock Today: Price, Dividend Hike, Value Pivot and Holiday Catalysts – December 4, 2025

McDonald’s (MCD) Stock Today: Price, Dividend Hike, Value Pivot and Holiday Catalysts – December 4, 2025

Updated: December 4, 2025 McDonald’s Corporation (NYSE: MCD) heads into the final stretch of 2025 as one of the market’s core defensive consumer names, but the story is no longer just about burgers and fries. Investors are weighing a fresh dividend hike, aggressive price cuts to win back budget‑strained diners, surging digital engagement, and a crowded field of analyst forecasts…
4 December 2025
Procter & Gamble (PG) Stock at 2‑Year Lows: Latest News, Forecasts & Outlook as of 4 December 2025

Procter & Gamble (PG) Stock at 2‑Year Lows: Latest News, Forecasts & Outlook as of 4 December 2025

Key takeaways for Procter & Gamble stock today (4 December 2025) If you’re seeing the name “Procter & Gamble Company (The) 3 stock” on certain European or structured‑product platforms, it typically refers to exposure to the same underlying NYSE‑listed PG shares (often via warrants or certificates) rather than a different class of equity. Gspriips 1. Procter & Gamble stock today:…
Coherent Corp (COHR) Stock Jumps to Fresh Highs on 300mm Silicon Carbide Breakthrough – Price, Forecast & AI Datacenter Outlook as of December 4, 2025

Coherent Corp (COHR) Stock Jumps to Fresh Highs on 300mm Silicon Carbide Breakthrough – Price, Forecast & AI Datacenter Outlook as of December 4, 2025

Coherent Corp (NYSE: COHR) is back in the spotlight. As of early afternoon trading on December 4, 2025, the photonics and materials specialist is trading around $179 per share, up roughly 4.8–5% on the day, after touching an intraday high above $186 on heavy volume. StockAnalysis The move extends a powerful rally driven by AI datacenter demand, a strong earnings…
Rocket Lab (RKLB) Stock Soars on Record Launches and JAXA Deal Despite Neutron Delay – December 2025 Outlook

Rocket Lab (RKLB) Stock Soars on Record Launches and JAXA Deal Despite Neutron Delay – December 2025 Outlook

Rocket Lab Corporation’s stock (NASDAQ: RKLB) is back in rally mode in early December 2025. After a sharp pullback in November tied to delays in its next‑generation Neutron rocket, shares are climbing again on the back of record launch activity, new Japanese contracts, and a wave of fresh analyst upgrades and commentary. Via Satellite Below is a detailed, news‑driven look…
Lumentum (LITE) Stock Hits Record High on AI Datacenter Boom as Analysts Flag 20–40% Downside Risk – December 4, 2025

Lumentum (LITE) Stock Hits Record High on AI Datacenter Boom as Analysts Flag 20–40% Downside Risk – December 4, 2025

Lumentum Holdings Inc. (NASDAQ: LITE) has surged into the center of the AI infrastructure trade. As of December 4, 2025, the stock is trading around $325–$326 per share, near a fresh all‑time high, and has risen well over 200% in the last 12 months. StockAnalysis Yet behind the euphoria, a growing chorus of Wall Street and independent analysts warn that…
Circle Internet Group (CRCL) Stock on December 4, 2025: Volatile Rebound, Big Earnings Beat and Divided 2026 Forecasts

Circle Internet Group (CRCL) Stock on December 4, 2025: Volatile Rebound, Big Earnings Beat and Divided 2026 Forecasts

Circle Internet Group, Inc. (NYSE: CRCL) – the company behind the USDC and EURC stablecoins – is back in the spotlight after a violent few months that have turned it into one of 2025’s most hotly debated post‑IPO stocks. As of the close on December 4, 2025, Circle shares finished around the mid‑$80s (about $85.74), easing slightly after an 11%…
Kroger (KR) Stock Slides After Q3 2025 Earnings: Guidance, $2.6B Charge and Fresh Analyst Forecasts

Kroger (KR) Stock Slides After Q3 2025 Earnings: Guidance, $2.6B Charge and Fresh Analyst Forecasts

CINCINNATI — December 4, 2025 Kroger Co. (NYSE: KR) shares dropped roughly 4–5% on Thursday after the supermarket giant reported third‑quarter 2025 results that featured a sizable $2.6 billion impairment charge, a slight sales miss and a narrowed full‑year sales outlook — even as profits and margins came in strong and guidance for earnings per share was nudged higher. Kroger…
Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025?

Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025?

Updated: December 4, 2025 Amgen Inc. (NASDAQ: AMGN) has quietly turned into one of 2025’s standout large‑cap healthcare winners. The biotech heavyweight is trading just below fresh 52‑week highs, powered by a clean sweep of earnings beats, a deepening obesity‑drug story around its MariTide program, and full FDA approval for its lung‑cancer therapy Imdelltra. At the same time, investors are…
BitMine Immersion Technologies (BMNR) Stock: $150M New ETH Buy, FY25 Earnings and 2026 Staking Pivot – Full Outlook as of December 4, 2025

BitMine Immersion Technologies (BMNR) Stock: $150M New ETH Buy, FY25 Earnings and 2026 Staking Pivot – Full Outlook as of December 4, 2025

BitMine Immersion Technologies, Inc. (NYSE American: BMNR) has become one of the most talked‑about crypto‑linked stocks on Wall Street. As of mid‑day on December 4, 2025, BMNR trades around $34–35 per share, giving the company a market capitalization of roughly $13.2 billion. StockAnalysis Behind that valuation sits a highly unusual balance sheet: BitMine now holds about 3.7 million Ether (ETH)…
Check Point Software (CHKP) Stock Today: AI Firewall Launch, $1.75B Convertible Notes and Wall Street Forecasts

Check Point Software (CHKP) Stock Today: AI Firewall Launch, $1.75B Convertible Notes and Wall Street Forecasts

Date: December 4, 2025Ticker: Check Point Software Technologies Ltd. (NASDAQ: CHKP) Key Takeaways This article is for information and news purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Where CHKP Stock Stands on December 4, 2025 As of late trading on December 4, 2025, Check Point Software shares are changing hands…
1 728 729 730 731 732 812

Stock Market Today

  • Institutional Investors Hold 46% Stake in Capital Limited (LON:CAPD)
    January 25, 2026, 4:38 AM EST. Capital Limited (LON:CAPD) sees 46% ownership by institutional investors, highlighting significant influence over the stock's price movements. Seven major shareholders collectively own 54%, with insiders holding 16%. Top investors include Aegis Financial Corporation, and executive Jamie Boyton each holding 10%. Institutional presence indicates credibility but poses potential volatility if these investors shift sentiment simultaneously. Hedge fund holdings remain low. The company's inclusion in major indices attracts institutional attention, signaling market relevance. Analysts maintain varied coverage, emphasizing the need to consider both institutional trends and future earnings prospects when evaluating Capital's investment potential.
Go toTop